Clinical Trial Update: Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating maintenance versus reduction of immunosuppression in renal transplant patients hospitalized with COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Disease

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: COVID, Kidney Transplant; Complications | Phase 2, Phase 3 | Status: WITHDRAWN